Top of the morning to you, and a superb one it’s, regardless of the grey skies hovering over the Pharmalot campus. We’re doing our greatest to keep up sunny spirits, although, as a result of as soon as once more, we recall some useful knowledge from the Morning Mayor, who taught us that “Each new day needs to be unwrapped like a treasured present.” To rejoice the notion, we’re brewing nonetheless extra cups of stimulation and welcoming you to hitch us. Our alternative right this moment is mocha hazelnut. Bear in mind, a prescription is just not required. So no want to worry over rebates. In the meantime, listed below are just a few gadgets of curiosity. Hope you may have a significant and productive day and, in fact, do keep in contact. …
A U.S. Home Committee investigation discovered that pharmacy profit managers promise to manage prices, however have as an alternative steered sufferers towards higher-priced medicines and affiliated pharmacies — steps that improve spending and cut back affected person alternative, The Wall Road Journal stories. The PBMs devised formularies of most popular medicines that inspired use of higher-priced medication over lower-priced options, in keeping with the report by the Republican-led Home Committee on Oversight and Accountability. The PBMs have additionally made sufferers pay extra to make use of their native pharmacy reasonably than a mail-order pharmacy affiliated with the PBM.
Following the discharge of extensively touted research outcomes for a Gilead Sciences HIV therapy, a brand new evaluation finds the medication — referred to as lenacapavir — may very well be made for as little as $26 to $40 per particular person every year, which the researchers argue might alleviate considerations about restricted entry in lots of nations, STAT tells us. The drugs drew appreciable consideration final month after a late-stage scientific trial discovered that twice-a-year injections fully protected cisgender ladies from contracting HIV. But the $42,250 price ticket and a scarcity of specifics about licensing to poorer nations has triggered consternation
Get limitless entry to award-winning journalism and unique occasions.